MedTrace Logo

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD

NCT03658642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5047

Last updated 2022-06-28

Study results available
· View outcomes & findings →

Summary

Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (CDS) represents a potential approach to accelerate adoption of this best practice into routine emergency care. The goal of this trial is to determine whether implementation of a user-centered clinical decision support (CDS) system can increase adoption of initiation of BUP into the routine emergency care of individuals with OUD.

Conditions

  • Clinical Decision Support
  • Buprenorphine
  • Opioid-use Disorder

Interventions

BEHAVIORAL

Clinical Decision Support (CDS)

This clinical decision support tool will improve the clinician's ability to identify those with OUD, initiate BUP and refer the patient to ongoing Medication Assisted Treatment (MAT)

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of North Carolina

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • The Cooper Health System

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Edward Melnick, MD, MHS · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2021-05-14
Completion
2021-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658642 on ClinicalTrials.gov